BR9812222A - Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação - Google Patents

Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação

Info

Publication number
BR9812222A
BR9812222A BR9812222-3A BR9812222A BR9812222A BR 9812222 A BR9812222 A BR 9812222A BR 9812222 A BR9812222 A BR 9812222A BR 9812222 A BR9812222 A BR 9812222A
Authority
BR
Brazil
Prior art keywords
preparation
separate
diagnostic
prothrombin complex
pharmaceutical
Prior art date
Application number
BR9812222-3A
Other languages
English (en)
Inventor
Yendra Linnau
Peter Turecek
Hans-Peter Schwarz
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of BR9812222A publication Critical patent/BR9812222A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"PREPARAçãO FARMACêUTICA SEPARADA DE COMPLEXO DE PROTROMBINA, PREPARAçãO DIAGNóSTICA, E, UTILIZAçãO DE UMA PREPARAçãO". Descreve-se uma preparação farmacêutica separada de complexo de protrombina, que contém pelo menos 2 fatores individuais dependentes de vitamina K altamente purificados.
BR9812222-3A 1997-09-19 1998-09-17 Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação BR9812222A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
PCT/AT1998/000224 WO1999015196A1 (de) 1997-09-19 1998-09-17 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Publications (1)

Publication Number Publication Date
BR9812222A true BR9812222A (pt) 2000-07-18

Family

ID=3516739

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812222-3A BR9812222A (pt) 1997-09-19 1998-09-17 Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação

Country Status (10)

Country Link
EP (1) EP1015020A1 (pt)
JP (1) JP2001517636A (pt)
AT (1) AT409334B (pt)
AU (1) AU743102B2 (pt)
BR (1) BR9812222A (pt)
CA (1) CA2304396A1 (pt)
HU (1) HUP0003681A1 (pt)
NO (1) NO20001415L (pt)
SK (1) SK4022000A3 (pt)
WO (1) WO1999015196A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0402315A3 (en) 2001-12-21 2009-03-30 Novo Nordisk Healthcare Ag Liquid composition of factor vii polypeptides
EP1485121A4 (en) * 2002-03-08 2007-11-07 Lilly Co Eli ACTIVE C PROTEIN FORMULATIONS
CN1671410B (zh) 2002-06-21 2010-05-12 诺和诺德医疗保健公司 因子ⅶ多肽的稳定化固体组合物
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
AU2004241698A1 (en) 2003-05-23 2004-12-02 Novo Nordisk Health Care Ag Protein stabilization in solution
ES2382157T3 (es) 2003-06-25 2012-06-05 Novo Nordisk Health Care Ag Composición líquida de polipépttidos del factor VII
CA2534028A1 (en) 2003-08-14 2005-02-24 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of factor vii polypeptides
EP3378470A1 (en) 2003-12-19 2018-09-26 Novo Nordisk Health Care AG Stabilised compositions of factor vii polypeptides
CN101151533A (zh) * 2005-02-16 2008-03-26 伊利诺斯大学理事会 基于金属螯合脂质的促凝血剂
DE602006021290D1 (de) 2005-03-04 2011-05-26 Univ Illinois Modulator von coagulationskaskaden und fibrinolytischen kaskaden
WO2009046194A2 (en) 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
EP2624859B1 (en) 2010-10-06 2017-03-01 Medimmune Limited Factor ii alone or in combination with further factors for treatment of impaired haemostasis associated with dilutional coagulopathy
KR102658958B1 (ko) * 2017-02-09 2024-04-22 체에스엘 베링 게엠베하 출혈의 치료 또는 예방에 사용하기 위한 혈액 응고 인자 대체품

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
DK0796623T3 (da) * 1996-03-20 2005-08-01 Baxter Ag Farmaceutisk præparat til behandling af blodkoagulationslidelser

Also Published As

Publication number Publication date
EP1015020A1 (de) 2000-07-05
AU9244998A (en) 1999-04-12
AU743102B2 (en) 2002-01-17
SK4022000A3 (en) 2000-09-12
CA2304396A1 (en) 1999-04-01
JP2001517636A (ja) 2001-10-09
AT409334B (de) 2002-07-25
WO1999015196A1 (de) 1999-04-01
NO20001415L (no) 2000-05-19
HUP0003681A1 (hu) 2001-02-28
ATA159197A (de) 2001-12-15
NO20001415D0 (no) 2000-03-17

Similar Documents

Publication Publication Date Title
BR9812222A (pt) Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação
TR200001603T2 (tr) Yeni bileşikler
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
TR199700660T1 (xx) Yeni farnezil transferaz �nleyiciler.
DK0801564T3 (da) Anvendelse af nebivolol som et antiatherogent middel
HUP0001020A2 (hu) Sztanolkészítmény és annak felhasználása
BR9609653A (pt) Compostos e composições farmacêuticas contendo os mesmos
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
TNSN97031A1 (fr) Melanges insolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments.
DE69723728D1 (de) Totalsynthese des amino hip analogen von didemnin a
GB2380939B (en) Treatment or prevention of auto-immune diseases
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
NO980296D0 (no) Forbedrede terapeutiske midler
ES2175181T3 (es) Analogos hexaciclicos de camptotecina y su procedimiento de preparacion.
FR2700268B1 (fr) Composition cosmétique ou pharmaceutique, notamment dermatologique, contenant un extrait de Vismia.
TR200003352T2 (tr) Yeni pentaerythrit türevleri, bunların imalatı ve kullanımları ile bunların sentezi için ara maddeler
AR004088A1 (es) Gonadotropinas compuestas por una subunidad alfa y una subunidad beta
BR9809286A (pt) Processos para redução de fibrinogênio
DK0673913T3 (da) Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler
FR2702768B1 (fr) Nouveaux mono-amides de la Carpaïne, leur préparation et leur application en tant que médicaments.
ES2162123T3 (es) Dihidrato del (2r,3s)-3-terc.-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-10beta-diacetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1-hidroxi-9-oxo-19-nor-ciclopropa(g)tax-11-eno-13alfa-ilo y su procedimiento de preparacion.
UA30250A (uk) Антиоксидантний засіб

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]